Search results for "Chronic kidney disease"
MKSAP Quiz: Follow-up for microscopic hematuria
A 35-year-old woman is evaluated during a follow-up visit for recurrent microscopic hematuria without proteinuria. Following a physical exam, lab studies, and kidney ultrasound, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2022/03/08/3.htm
8 Mar 2022
Allopurinol not associated with increased mortality in patients with CKD, gout
The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022
Equation for kidney failure risk that excludes race shows better sensitivity, specificity than eGFR alone
The four-variable equation includes age, sex, estimated glomerular filtration rate (eGFR), and urinary albumin-creatinine ratio.
https://immattersacp.org/weekly/archives/2022/01/11/4.htm
11 Jan 2022
Diagnosis at 10 paces for bitemporal wasting
In a new series, Pearls from I.M. Peers, Paul Dallas, MD, MACP, explains how making a simple observation in a patient could indicate a serious diagnosis.
https://immattersacp.org/archives/2022/01/diagnosis-at-10-paces-for-bitemporal-wasting.htm
1 Jan 2022
Improving HCV treatment and screening in primary care
Amid global calls to eliminate viral hepatitis, efforts are underway to screen asymptomatic adults for hepatitis C and overcome barriers to treatment.
https://immattersacp.org/archives/2022/01/improving-hcv-treatment-and-screening-in-primary-care.htm
1 Jan 2022
GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes
An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://immattersacp.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021
MKSAP Quiz: Follow-up for stable chronic kidney disease
A 57-year-old man is evaluated during follow-up for stable chronic kidney disease diagnosed 1 year ago. He also has type 2 diabetes mellitus, hyperlipidemia, and peripheral artery disease. On physical examination, blood pressure is 128/74 mm Hg, pulse rate is 65/min, and respiration rate is 18/min. Bilateral carotid and lower abdominal quadrant bruits are heard. Peripheral extremity pulses are diminished. The remainder of the examination is normal. After laboratory studies, what is the appropriate management?
https://immattersacp.org/weekly/archives/2021/11/09/3.htm
9 Nov 2021
NKF-ASN task force issues final report on use of race in diagnosing kidney disease
Effective immediately in the U.S., estimated glomerular filtration rate should be calculated with an updated equation that does not include a race modifier for Black patients, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) said.
https://immattersacp.org/weekly/archives/2021/09/28/2.htm
28 Sep 2021
MKSAP Quiz: Difficult-to-control hypertension
A 62-year-old man is evaluated during a follow-up visit for difficult-to-control hypertension. He also has chronic kidney disease and hyperlipidemia. Following a physical exam and lab studies, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2021/08/24/3.htm
24 Aug 2021